We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$82.9B
AUM Growth
+$1.82B
Cap. Flow
-$3.2B
Cap. Flow %
-3.86%
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Financials 19.43%
3 Healthcare 10.94%
4 Consumer Discretionary 8.03%
5 Communication Services 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GES
1376
DELISTED
Guess Inc
GES
$204K ﹤0.01%
+10,500
New +$225K
LBTYA icon
1377
Liberty Global Class A
LBTYA
$3.62B
$204K ﹤0.01%
10,450
+200
+2% +$4.06K
APPS icon
1378
Digital Turbine
APPS
$975M
$190K ﹤0.01%
+15,400
New +$207K
PKE icon
1379
Park Aerospace
PKE
$737M
$190K ﹤0.01%
14,100
ACB
1380
Aurora Cannabis
ACB
$173M
$183K ﹤0.01%
26,278
+2,146
+9% +$18.8K
WHWK
1381
Whitehawk Therapeutics
WHWK
$190M
$174K ﹤0.01%
24,083
UNIT
1382
Uniti Group
UNIT
$2.36B
$174K ﹤0.01%
49,100
+3,000
+7% +$15.9K
KEEL
1383
Keel Infrastructure Corp
KEEL
$2.4B
$165K ﹤0.01%
173,255
+28,199
+19% +$26.4K
SBH icon
1384
Sally Beauty Holdings
SBH
$1.43B
$164K ﹤0.01%
+10,500
New +$163K
PRLD icon
1385
Prelude Therapeutics
PRLD
$366M
$162K ﹤0.01%
28,440
LEV
1386
DELISTED
The Lion Electric Company
LEV
$158K ﹤0.01%
84,920
+18,476
+28% +$41.7K
FCF icon
1387
First Commonwealth Financial
FCF
$2.18B
$154K ﹤0.01%
12,400
CCCC icon
1388
C4 Therapeutics
CCCC
$385M
$152K ﹤0.01%
48,453
LBPH
1389
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$148K ﹤0.01%
37,611
ADCT icon
1390
ADC Therapeutics
ADCT
$134M
$146K ﹤0.01%
74,690
CWK icon
1391
Cushman & Wakefield Ltd
CWK
$3.14B
$145K ﹤0.01%
+13,800
New +$177K
SNTI icon
1392
Senti Biosciences Holdings
SNTI
$10.6M
$140K ﹤0.01%
11,829
ASX icon
1393
ASE Group
ASX
$77.3B
$133K ﹤0.01%
+16,662
New +$122K
AMAM
1394
DELISTED
Ambrx Biopharma Inc
AMAM
$124K ﹤0.01%
+13,900
New +$69.9K
TILE icon
1395
Interface
TILE
$1.99B
$119K ﹤0.01%
+14,600
New +$144K
GHIXW
1396
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$115K ﹤0.01%
500,000
CPAAW
1397
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$100K ﹤0.01%
499,999
MGTX icon
1398
MeiraGTx Holdings
MGTX
$1.09B
$99.7K ﹤0.01%
19,287
SCRMW
1399
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$97.9K ﹤0.01%
416,666
NUVB icon
1400
Nuvation Bio
NUVB
$2.2B
$87.6K ﹤0.01%
52,800

Similar funds

TD Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.

  • TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
  • TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
  • TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
  • TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
  • TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
  • TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
  • TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.